ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Novartis receives European Commission approval for self-administration of Xolair® across all indications
December 14, 2018Novartis today announced that the European Commission (EC) has approved Xolair® (omalizumab) prefilled syringe (PFS) for self-administration, allowing patients with severe allergic asthma (SAA) and chronic spontaneous urticaria (CSU) to administer their o
Pharma Sources Insight January 2025
